Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Deep Learning for in Vivo Near-Infrared Imaging.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Deep Learning Fluorescence Imaging of Visible to NIR‐II Based on Modulated Multimode Emissions Lanthanide Nanocrystals

In vivo NIR-II fluorescence imaging for biology and medicine

Advances on <i>in vivo</i> Fluorescence Bioimaging in the Second Near-Infrared Window

Near-infrared-II Deep Tissue Fluorescence Microscopy and Application

Deep-learning based image reconstruction for MRI-guided near-infrared spectral tomography

NIR-II Fluorescence Imaging for In Vivo Quantitative Analysis

Advanced Fluorescence Imaging Technology in the Near-Infrared-II Window for Biomedical Applications

Progress of NIR-II fluorescence imaging technology applied to disease diagnosis and treatment

Near-Infrared Fluorophore-Doped Nanoparticles For In Vitro And In Vivo Bioimaging

Near‐Infrared‐II Quantum Dots for In Vivo Imaging and Cancer Therapy

NIR-II Fluorescence in Vivo Functional Bioimaging

Fluorescence Imaging In Vivo at Wavelengths beyond 1500 nm

Advanced NIR‐II Fluorescence Imaging Technology for In Vivo Precision Tumor Theranostics

Near-infrared-II Fluorescence Imaging for Tumor Diagnosis and Therapy

Biocompatible Near-Infrared Fluorescent Nanoparticles for Macro and Microscopic in Vivo Functional Bioimaging.

Aggregation-Induced Emission Luminogen with Near-Infrared-II Excitation and Near-Infrared-I Emission for Ultradeep Intravital Two-Photon Microscopy

Research of NIR-II small animal living fluorescence imaging system

Recent Progress of Near-Infrared Fluorescence in vivo Bioimaging in the Second and Third Biological Window

Second Near-Infrared Window Fluorescence Nanoprobes for Deep-Tissue in Vivo Multiplexed Bioimaging.